- Home
- OPFI vs AMRN Comparison
OPFI vs AMRN Comparison
Compare OPFI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- AMRN
- Stock Information
- Founded
- OPFI 2009
- AMRN 1989
- Country
- OPFI United States
- AMRN Ireland
- Employees
- OPFI N/A
- AMRN N/A
- Industry
- OPFI Finance: Consumer Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- OPFI Finance
- AMRN Health Care
- Exchange
- OPFI Nasdaq
- AMRN Nasdaq
- Market Cap
- OPFI 174.4M
- AMRN 189.2M
- IPO Year
- OPFI N/A
- AMRN 1993
- Fundamental
- Price
- OPFI $11.91
- AMRN $0.56
- Analyst Decision
- OPFI Buy
- AMRN Buy
- Analyst Count
- OPFI 2
- AMRN 1
- Target Price
- OPFI $7.50
- AMRN N/A
- AVG Volume (30 Days)
- OPFI 1.5M
- AMRN 1.8M
- Earning Date
- OPFI 03-06-2025
- AMRN 02-27-2025
- Dividend Yield
- OPFI N/A
- AMRN N/A
- EPS Growth
- OPFI 775.86
- AMRN N/A
- EPS
- OPFI 0.38
- AMRN N/A
- Revenue
- OPFI $260,661,000.00
- AMRN $241,021,000.00
- Revenue This Year
- OPFI N/A
- AMRN N/A
- Revenue Next Year
- OPFI $6.51
- AMRN N/A
- P/E Ratio
- OPFI $31.50
- AMRN N/A
- Revenue Growth
- OPFI 23.85
- AMRN N/A
- 52 Week Low
- OPFI $2.35
- AMRN $0.43
- 52 Week High
- OPFI $11.96
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- OPFI 78.36
- AMRN 62.52
- Support Level
- OPFI $6.81
- AMRN $0.43
- Resistance Level
- OPFI $8.73
- AMRN $0.49
- Average True Range (ATR)
- OPFI 0.80
- AMRN 0.04
- MACD
- OPFI 0.38
- AMRN 0.01
- Stochastic Oscillator
- OPFI 99.03
- AMRN 96.07
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.